Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability

Journal of Pathology

Volumn 211, Issue 5, 2007, Pages 516-523

  Hirata, T ^a   Yamamoto, H ^a   Taniguchi, H ^a   Horiuchi, S ^a   Oki, M ^a   Adachi, Y ^a   Imai, K ^a   Shinomura, Y ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antigen presentation machinery; Gastric cancer; HLA class I; Immune surveilance; Microsatellite instability

Indexed keywords

BETA 2 MICROGLOBULIN; CALNEXIN; CHAPERONE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; LOW MOLECULAR WEIGHT POLYPEPTIDE PROTEASOME SUBUNIT 10; LOW MOLECULAR WEIGHT POLYPEPTIDE PROTEASOME SUBUNIT 2; LOW MOLECULAR WEIGHT POLYPEPTIDE PROTEASOME SUBUNIT 7; MEMBRANE PROTEIN; PROTEASOME ACTIVATOR 28ALPHA; PROTEASOME ACTIVATOR 28BETA; PROTEIN P55; PROTEIN SEC31; PROTEIN SEC63; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSCRIPTION REGULATION; TUMOR IMMUNITY;

ANTIGENS, NEOPLASM; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DOWN-REGULATION; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERONS; LOSS OF HETEROZYGOSITY; METHYLATION; MICROSATELLITE INSTABILITY; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; UP-REGULATION;

EID: 33947646821     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2142     Document Type: Article

References (27)

1. Yamamoto H, Imai K, Perucho M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J Gastroenterol 2002;37:153-163.
2. Ottini L, Falchetti M, Lupi R, Rizzolo P, Agnese V, Colucci G, et al. Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol 2006;17(suppl 7):vii97-vii102.
3. Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006;131:729-737.
4. Ropero S, Fraga M, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M, et al. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet 2006;38:566-569.
5. Guidoboni M, Gafa R, Viel A, Doglioni C, Russo A, Santini A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001;159:297-304.
6. Bodmer W, Bishop T, Karran P. Genetic steps in colorectal cancer. Nat Genet 1994;6:217-219.
7. Bicknell DC, Rowan A, Bodmer WF. β2-microglobutin gene mutations: a study of established colorectal cell lines and fresh tumours. Proc Natl Acad Sci USA 1994;91:4751-4756.
8. Bicknell DC, Kaklamanis L, Hampson R, Bodmer WF, Karran P. Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 1996;6:1695-1697.
9. Kloor M, Becker C, Benner A, Woerner SM, Gebert J, Ferrone S, et al. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res 2005;65:6418-6424.
10. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 2000;74:181-273.
11. Lopez-Nevot MA, Esteban F, Ferron A, Gutierrez J, Oliva MR, Romero C, et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 1989;59:221-226.
12. Klein B, Klein T, Nyska A, Shapira J, Figer A, Schwartz A, et al. Expression of HLA class I and class II in gastric carcinoma in relation to pathologic stage. Tumour Biol 1991;12:68-74.
13. Rockett JC, Darnton SJ, Crocker J, Matthews HR, Morris AG: Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. J Clin Pathol 1995;48:539-544.
14. Wang XC, Zhang JQ, Shen YQ, Miao FQ, Xie W. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer. J Exp Clin Cancer Res 2006;25:115-119.
15. Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, et al. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Oncogene 2004;23:8876-8886.
16. Dutta N, Majumder D, Gupta A, Mazumder DN, Banerjee S. Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction. Hum Immunol 2005;66:164-169.
17. Yamamoto H, Itoh F, Fukushima H, Adachi Y, Itoh H, Hinoda Y, et al. Frequent Bax frameshift mutations in gastric cancer with high but not low microsatellite instability. J Exp Clin Cancer Res 1999;18:103-106.
18. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
19. Matsui M, Ikeda M, Akatsuka T. High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation. Biochem Biophys Res Commun 2001;280:1008-1014.
20. Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res 2001;61:1095-1099.
21. Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, et al. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001;22:1615-1623.
22. Woerner SM, Gebert J, Yuan YP, Sutter C, Ridder R, Bork P, et al. Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. Int J Cancer 2001;93:12-19.
23. Kang JK, Yoon SJ, Kim NK, Heo DS. The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines. Int J Oncol 2000;16:1159-1163.
24. Menon AG, Morreau H, Tollenaar RA, Alphenaar E, Van Puijenbroek M, Putter H, et al. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients. Lab Invest 2002;82:1725-1733.
25. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005;45:629-656.
26. Kaklamanis L, Townsend A, Doussis-Anagnostopoulou IA, Mortensen N, Harris AL, Gatter KC. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 1994;145:505-509.
27. Cabrera CM, Jimenez P, Cabrera T, Esparza C, Ruiz-Cabello F, Garrido F. Total loss of MHC class I in colorectal tumours can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumours and LMP7/TAP2 downregulation in MSI-negative tumours. Tissue Antigens 2003;61:211-219.